MicroRNA and diabetic retinopathy—biomarkers and novel therapeutics

Diabetic retinopathy (DR) accounts for ~80% of legal blindness in persons aged 20–74 years and is associated with enormous social and health burdens. Current therapies are invasive, non-curative, and in-effective in 15–25% of DR patients. This review outlines the potential utility of microRNAs (miRN...

Descripción completa

Detalles Bibliográficos
Autores principales: Smit-McBride, Zeljka, Morse, Lawrence S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Novel Tools and Therapies for Ocular Regeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421969/
https://www.ncbi.nlm.nih.gov/pubmed/34532417
http://dx.doi.org/10.21037/atm-20-5189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421969/
https://www.ncbi.nlm.nih.gov/pubmed/34532417
http://dx.doi.org/10.21037/atm-20-5189

Ejemplares similares